Fernwood Investment Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $7.64M | Buy |
278,330
+16,595
| +6% | +$455K | 2.66% | 8 |
|
|
2024
Q3 | $6.66M | Buy |
261,735
+6,200
| +2% | +$158K | 2.17% | 10 |
|
|
2024
Q2 | $6.47M | Buy |
255,535
+10,415
| +4% | +$264K | 2.01% | 12 |
|
|
2024
Q1 | $7.58M | Buy |
245,120
+9,600
| +4% | +$297K | 2.21% | 8 |
|
|
2023
Q4 | $9.51M | Sell |
235,520
-100
| -0% | -$4.04K | 3.13% | 4 |
|
|
2023
Q3 | $6.21M | Sell |
235,620
-4,275
| -2% | -$113K | 2.23% | 9 |
|
|
2023
Q2 | $4.13M | Buy |
239,895
+2,920
| +1% | +$50.2K | 1.46% | 17 |
|
|
2023
Q1 | $3.93M | Buy |
236,975
+33,975
| +17% | +$563K | 1.51% | 16 |
|
|
2022
Q4 | $1.55M | Sell |
203,000
-1,550
| -0.8% | -$11.8K | 0.64% | 48 |
|
|
2022
Q3 | $2.03M | Buy |
204,550
+20,650
| +11% | +$205K | 0.86% | 30 |
|
|
2022
Q2 | $1.67M | Buy |
183,900
+11,575
| +7% | +$105K | 0.72% | 40 |
|
|
2022
Q1 | $1.75M | Buy |
172,325
+8,925
| +5% | +$90.6K | 0.61% | 48 |
|
|
2021
Q4 | $2.73M | Buy |
163,400
+5,502
| +3% | +$91.8K | 0.89% | 28 |
|
|
2021
Q3 | $7.4M | Buy |
157,898
+4,226
| +3% | +$198K | 2.54% | 7 |
|
|
2021
Q2 | $9.37M | Buy |
153,672
+2,587
| +2% | +$158K | 3.1% | 2 |
|
|
2021
Q1 | $9.31M | Buy |
151,085
+250
| +0.2% | +$15.4K | 3.42% | 2 |
|
|
2020
Q4 | $10.7M | Buy |
150,835
+7,000
| +5% | +$498K | 4.23% | 1 |
|
|
2020
Q3 | $5.4M | Sell |
143,835
-1,265
| -0.9% | -$47.5K | 2.55% | 9 |
|
|
2020
Q2 | $4.73M | Buy |
145,100
+41,850
| +41% | +$1.36M | 2.34% | 7 |
|
|
2020
Q1 | $2.99M | Sell |
103,250
-1,150
| -1% | -$33.3K | 1.91% | 11 |
|
|
2019
Q4 | $3.66M | Buy |
104,400
+9,200
| +10% | +$322K | 1.75% | 10 |
|
|
2019
Q3 | $2.04M | Buy |
+95,200
| New | +$2.04M | 1.01% | 30 |
|